Lilly's Foundayo Demonstrates Weight Loss Across Menopause Stages

Eli Lilly reported new post-hoc results showing that women with obesity or overweight who took the highest dose of Foundayo achieved significant weight loss at every stage of menopause. The findings, based on analyses of more than 1,500 female patients, support the drug's efficacy in a key patient subgroup. The update is positive for Lilly's obesity franchise, though the article does not include pricing, sales, or regulatory changes.

Analysis

Eli Lilly reported new post-hoc results showing that women with obesity or overweight who took the highest dose of Foundayo achieved significant weight loss at every stage of menopause. The findings, based on analyses of more than 1,500 female patients, support the drug's efficacy in a key patient subgroup. The update is positive for Lilly's obesity franchise, though the article does not include pricing, sales, or regulatory changes.